Landos Biopharma Inc. Gains 167.5%
Mon, Mar 25, 2024 at 07:25 PM
Landos Biopharma Inc. (LABP:NASDAQ) shot up at $21.4, a gain of 167.5%. On Mon, Mar 25, 2024, LABP:NASDAQ hit a New 2-Week High of $21.4. The stock got featured on our News Catalysts scanner on Mon, Mar 25, 2024 at 03:21 PM in the 'ACQUISITION' category. From Mon, Mar 11, 2024, the stock recorded 70.00% Up Days and 54.55% Green Days
About Landos Biopharma Inc. (LABP:NASDAQ)
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.
Top 10 Gainers:
- Landos Biopharma Inc. (LABP:NASDAQ), 167.5%
- F45 Training Holdings Inc. (FXLV:NYSE), 66.67%
- MoneyHero Limited (MNY:NASDAQ), 63.5%
- Linkage Global Inc (LGCB:NASDAQ), 46.4%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 36.63%
- Puyi Inc. (PUYI:NASDAQ), 33.93%
- noco-noco Inc. (NCNC:NASDAQ), 30.46%
- Reddit Inc. Class A (RDDT:NYSE), 30%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 29.8%
- Next.e.GO N.V. (EGOX:NASDAQ), 29.52%